TissueCypher is a laboratory test that can help predict the risk of developing esophageal cancer in patients diagnosed with Barrett’s esophagus (BE).

Half of all cancer deaths worldwide are attributable to modifiable risk factors, according to The Cancer Atlas.

A capsule-sponge test may help identify patients with Barrett’s esophagus who are at low risk for dysplasia or esophageal ...

Esophageal cancer is emerging as an increasingly serious health concern in Rwanda, with new cases persistently rising over the past five years. According to data from the Rwanda Biomedical Center (RBC ...

Further data could back zanidatamab as advanced treatment for HER2-positive advanced gastroesophageal adenocarcinoma.

This year, more than 22,000 Americans face a chilling diagnosis — esophageal cancer. A new 3-minute in-office test is ...

Discover the new EsoGuard test, touted as a non-invasive method for early detection of esophageal cancer that offers hope for ...

Not many people know this, but Times Leader Executive Editor Joe Soprano was an honorary male member of “the Fit Chicks” — an ...

The latest advancements in upper gastrointestinal (GI) cancer treatment include early detection tools, immunotherapy, targeted therapies, and surgery techniques.

This year, more than 22,000 Americans face a chilling diagnosis: esophageal cancer. Men are 3 to 4 times more likely to ...

Kevin VonderHaar and his siblings grew up in the Hibbing Bowling Center. It’s been in the family since the 1950s, when his ...

Joe Soprano, a career newsman who for years oversaw operations as the executive editor of the Times Leader, died over the ...